OncoCyte Corp (OCX)
2.77
-0.04
(-1.25%)
USD |
NASDAQ |
May 07, 12:26
OncoCyte Cash from Investing (TTM): -0.932M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.932M |
| September 30, 2023 | -1.975M |
| June 30, 2023 | -1.538M |
| March 31, 2023 | -2.779M |
| December 31, 2022 | -4.34M |
| September 30, 2022 | -3.939M |
| June 30, 2022 | -3.474M |
| March 31, 2022 | -7.25M |
| December 31, 2021 | -13.96M |
| September 30, 2021 | -14.06M |
| June 30, 2021 | -14.19M |
| March 31, 2021 | -13.83M |
| December 31, 2020 | -11.75M |
| September 30, 2020 | -12.47M |
| June 30, 2020 | -23.18M |
| March 31, 2020 | -18.65M |
| December 31, 2019 | -12.42M |
| Date | Value |
|---|---|
| September 30, 2019 | -11.20M |
| June 30, 2019 | 0.027M |
| March 31, 2019 | 0.021M |
| December 31, 2018 | -0.031M |
| September 30, 2018 | -0.037M |
| June 30, 2018 | -0.058M |
| March 31, 2018 | 0.352M |
| December 31, 2017 | 0.843M |
| September 30, 2017 | 0.741M |
| June 30, 2017 | 0.762M |
| March 31, 2017 | 0.32M |
| December 31, 2016 | -0.181M |
| September 30, 2016 | 0.209M |
| June 30, 2016 | 0.262M |
| March 31, 2016 | 0.311M |
| December 31, 2015 | 0.315M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-23.18M
Minimum
Jun 2020
0.027M
Maximum
Jun 2019
-9.047M
Average
-11.20M
Median
Sep 2019
Cash from Investing (TTM) Benchmarks
| Fonar Corp | -3.114M |
| XWELL Inc | 5.65M |
| ProPhase Labs Inc | -1.369M |
| Applied DNA Sciences Inc | -1.141M |
| Veracyte Inc | 15.11M |